Skip to main content
53°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Recap: Regeneron Pharmaceuticals Q4 Earnings
February 04, 2022
Tickers
REGN
Tags
REGN
Benzinga
BZI/Recaps
From
Benzinga
Earnings Scheduled For February 4, 2022
February 04, 2022
Tickers
ADNT
AON
APD
BBU
Tags
AON
VRTS
REGN
From
Benzinga
Earnings Preview For Regeneron Pharmaceuticals
February 03, 2022
Tickers
REGN
Tags
Earnings
BZI/EP
Market News
From
Benzinga
What This FDA News Could Mean for Pfizer
February 01, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
Market News
LLY
REGN
From
Motley Fool
Should Investors Sell Eli Lilly After This Recent Regulatory News?
February 01, 2022
Tickers
LLY
REGN
Tags
Market News
LLY
REGN
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
February 01, 2022
Tickers
AGIO
AMYT
ATXI
CTIC
Tags
LEGN
REGN
General
From
Benzinga
3 Biotech Stocks That Could Boom or Bust in Q1
February 01, 2022
Tickers
OCGN
REGN
VRTX
Tags
OCGN
Hot Stocks
Market News
From
InvestorPlace
5 Things To Expect This Week
January 31, 2022
Tickers
AAPL
AMD
AMZN
APPS
Tags
UPS
GM
REGN
From
InvestorPlace
Analyst Ratings For Regeneron Pharmaceuticals
January 31, 2022
Tickers
REGN
Tags
REGN
Benzinga
Market News
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
FDA
Biotech
Small Cap
From
Benzinga
CHMP Backs Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6 - 11 Years With Type 2 Inflammation
January 31, 2022
Tickers
REGN
SNY
Tags
Benzinga
REGN
Briefs
From
Benzinga
Market corrections are good buying opportunities, says Goldman Sachs — but only when this happens
January 31, 2022
Tickers
CTRA
LPX
MRNA
REGN
Tags
MRNA
SWKS
REGN
From
MarketWatch
A Deep Dive Into the Video Game Industry
January 29, 2022
Tickers
AAL
AAPL
AMZN
ATVI
Tags
AAL
ZNGA
AAPL
From
Motley Fool
Can AbbVie Beat Pfizer in the Atopic Dermatitis Market?
January 29, 2022
Tickers
ABBV
PFE
REGN
SNY
Tags
ABBV
PFE
Market News
From
Motley Fool
Regeneron, Sanofi Withdraw FDA Application For Libtayo's Expanded Use
January 28, 2022
Tickers
REGN
SNY
Tags
General
SNY
Benzinga
From
Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
January 28, 2022
Tickers
ALXO
BGNE
BIIB
IBB
Tags
NRIX
RMD
BGNE
From
Benzinga
J&J exec says biotechs aren’t ‘necessarily on sale’ even after a challenging 2021
January 27, 2022
Tickers
BNTX
DRG
IBB
JNJ
Tags
JNJ
BNTX
REGN
From
MarketWatch
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
Tickers
BNTX
GSK
LLY
MRK
Tags
LLY
GSK
REGN
From
MarketWatch
A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Earnings, Fed Meeting
January 25, 2022
Tickers
AXP
BRO
IBM
JNJ
Tags
NIO
VZ
LLY
From
Benzinga
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
January 24, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
Benzinga
LLY
FDA
From
Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
January 24, 2022
Tickers
AZN
LLY
MRK
PFE
Tags
Top Stories
General
Covid/19
From
Benzinga
Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease
January 19, 2022
Tickers
REGN
SNY
Tags
Benzinga
REGN
Briefs
From
Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
January 19, 2022
Tickers
ADMA
ASLN
BGNE
CRDF
Tags
OCX
News
General
From
Benzinga
Regeneron Announces FDA Accepts For Review Libtayo In Combination With Chemotherapy For First-Line Treatment Of Advanced NSCLC
January 19, 2022
Tickers
REGN
Tags
FDA
Market News
Benzinga
From
Benzinga
2 Top Biotech Stocks to Buy and Hold for 10 Years
January 17, 2022
Tickers
MRK
MRNA
PFE
REGN
Tags
MRK
Market News
BAYR/Y
From
Motley Fool
3 Top Biotech Stocks to Buy Right Now
January 15, 2022
Tickers
GSK
NVS
REGN
SNY
Tags
SNY
Recent Press Releases
GSK
From
Motley Fool
WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge
January 14, 2022
Tickers
GSK
LLY
REGN
VIR
Tags
COVID/19 Coronavirus
Government
Benzinga
From
Benzinga
Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares
January 13, 2022
Tickers
CNTB
IMAB
LLY
PFE
Tags
Market News
contributors
PFE
From
Benzinga
1 Key Ratio All Investors Should Be Looking at When Buying Growth Stocks in 2022
January 13, 2022
Tickers
ARKK
FUBO
REGN
TSLA
Tags
Recent Press Releases
TSLA
ARKK
From
Motley Fool
Why JPMorgan Is Among Rob Sechan's Top Picks For 2022
January 10, 2022
Tickers
EOG
JPM
REGN
Tags
Long Ideas
JPM
EOG
From
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.